Journal database · 624 journals
Medicine SCI Journals: Review within 8 weeks
Medicine SCI Journals: Review within 8 weeks: 624 journals, each with impact factor, CAS zone, review time, APC, open-access status, annual volume and database indexing, and filterable by all of them.
Diabetes Epidemiology and Management
IF 2.2CAS Zone 4 · MedicineReview: about 26 days (submission to acceptance, publisher)APC charged, amount not publishedGold OA36 articles/yrESCI · Scopus · DOAJLivers
IF 2.2Review: about 7 weeksAPC charged, amount not publishedGold OA68 articles/yrESCI · Scopus · DOAJPharmacy
IF 2.2CAS Zone 4 · MedicineReview: median 42 days to acceptanceAPC charged, amount not publishedGold OA186 articles/yrESCI · DOAJJournal of Reconstructive Microsurgery
IF 2.19CAS Zone 2 · MedicineReview: about 1 monthSubscription128 articles/yrSCIE · ScopusPEDIATRIC INFECTIOUS DISEASE JOURNAL
IF 2.19CAS Zone 4 · MedicineReview: 2–4 weeksHybrid OA477 articles/yrSCIE · ScopusJournal of Ocular Pharmacology and Therapeutics
IF 2.18CAS Zone 4 · MedicineReview: about 1 monthHybrid OA92 articles/yrSCIE · ScopusRespiratory Care
IF 2.15CAS Zone 4 · MedicineReview: about 1 monthSubscription232 articles/yrSCIE · ScopusBlood Cells Molecules and Diseases
IF 2.13CAS Zone 4 · MedicineReview: median 55 days to acceptanceAPC about USD 4,030Hybrid OA36 articles/yrSCIE · ScopusJournal of Nursing Education
IF 2.12CAS Zone 4 · MedicineReview: 4–8 weeksHybrid OA165 articles/yrSCIE · SSCI · ScopusCANCER JOURNAL
IF 2.1CAS Zone 4 · MedicineReview: median 40 days to acceptanceSubscription45 articles/yrSCIE · ScopusJournal of Research in Nursing
IF 2.1CAS Zone 4 · MedicineReview: about 18 days (submission to acceptance, publisher)APC about USD 3,900Hybrid OA116 articles/yrESCI · ScopusRETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
IF 2.06CAS Zone 3 · MedicineReview: 3–6 weeksHybrid OA368 articles/yrSCIE · ScopusASAIO Journal
IF 2.05CAS Zone 3 · MedicineReview: 4–8 weeksHybrid OA512 articles/yrSCIE · ScopusJournal of Hand Surgery-European Volume
IF 2.05CAS Zone 3 · MedicineReview: 4–8 weeksAPC about USD 4,150Hybrid OA251 articles/yrSCIE · ScopusPlanta Medica
IF 2.04CAS Zone 4 · MedicineReview: about 1.7 monthsHybrid OA95 articles/yrSCIE · ScopusAnti-Cancer Drugs
IF 2.02CAS Zone 4 · MedicineReview: 4–8 weeksHybrid OA120 articles/yrSCIE · ScopusArab Journal of Urology
IF 2CAS Zone 4 · MedicineReview: about 29 days (first decision after review, publisher)APC charged, amount not publishedGold OA44 articles/yrESCI · Scopus · DOAJCurrent Cardiovascular Risk Reports
IF 2CAS Zone 4 · MedicineReview: median 20 days to acceptanceAPC about USD 4,090Hybrid OA23 articles/yrESCI · ScopusDrugs-Real World Outcomes
IF 2CAS Zone 4 · MedicineReview: about 8 weeksAPC about USD 3,190Gold OA61 articles/yrESCI · Scopus · DOAJEuropean Journal of Translational Myology
IF 2CAS Zone 4 · MedicineReview: median 29 days to acceptanceAPC charged, amount not publishedGold OA97 articles/yrESCI · Scopus · DOAJ
Browse by subject
About these figures
- Impact factor is the latest value LetPub lists. CAS zone is the major-category zone of the Chinese Academy of Sciences journal ranking, 2025 upgraded edition by default and switchable to the 2026 Xinrui edition; Top and review-journal flags are kept per edition.
- Review time is first the median from submission to acceptance of the journal's own articles from the last 24 months (Crossref / PubMed dates, at least 10 articles), then the publisher's stated submission-to-acceptance, final-decision or post-review decision time, then the community's average report. A publisher's "time to first decision" includes desk rejections and is used only when nothing else exists. Each source is labelled.
- APC is taken from DOAJ, OpenAlex, the publisher's website and LetPub, in that order; a hybrid journal's APC applies only to articles published open access.
- Articles per year is OpenAlex's count for the last complete year, or LetPub's annual article count when that is missing.